Jeffrey Lieberman, MD : Esketamine for Psychiatric Indications

Original Pub: HCP Live
Publish Date: February 17, 2019
Author: Kevin Kunzmann (Source: MD Magazine^® Interview with Dr. Lieberman)

In an interview with MD Magazine®, Dr. Jeffrey Lieberman explained how the potentially impeding approval of esketamine could force physicians to improvise dosing and continuation early into the first prescribing phase of in-need patients with depression.

Click to read published article (HCPLive.com)
Photo Source: Screen shot from MD Live video